HOT: Thiophosphonoacetate-modified oligoribonucleotides with RNA therapeutics in sight

The groups of Marvin Caruthers (University of Colorado at Boulder, USA) and Michael Gait (Medical Research Council Centre, Cambridge, UK) describe a new chemical synthesis and biological properties of 2’-O-methyl oligoribonucleotides (ORNs) containing internucleotide linkages modified with phosphonoacetate (PACE) and thiophosphonoacetate (thioPACE) groups.

ThioPACE modifications were found to greatly improve the efficiency of cell uptake and the potency of a 2′-O-Me-ORN miRNA122 inhibitor, showing that this class of modifications has great potential for applications in RNA therapeutics research.

As with all our HOT Articles, this OBC article is FREE for you to access, for a period of 4 weeks.



Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2′-O-methyl oligoribonucleotides
Richard N. Threlfall, Adrian G. Torres, Angelika Krivenko, Michael J. Gait and Marvin H. Caruthers
Org. Biomol. Chem., 2012, Advance Article
DOI: 10.1039/C1OB06614E

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)